BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23552757)

  • 1. [Pseudosarcomatous myofibroblastic proliferation of the bladder-case report].
    Ishikawa T; Ito F; Goya N; Suzuki K; Kanemitsu I; Yokota N; Nakazawa H; Fujibayashi M
    Hinyokika Kiyo; 2013 Feb; 59(2):125-7. PubMed ID: 23552757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudosarcomatous myofibroblastic proliferation of the urinary bladder.
    Hsiao CH; Wen YC; Lee LM
    J Chin Med Assoc; 2008 Aug; 71(8):431-4. PubMed ID: 18772126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-grade myofibroblastic proliferations of the urinary bladder.
    Alquati S; Gira FA; Bartoli V; Contini S; Corradi D
    Arch Pathol Lab Med; 2013 Aug; 137(8):1117-28. PubMed ID: 23899070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory myofibroblastic tumor of the bladder.
    Alderman M; Kunju LP
    Arch Pathol Lab Med; 2014 Oct; 138(10):1272-7. PubMed ID: 25268188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inflammatory myofibroblastic tumor of the bladder: a case report].
    Kinoshita T; Takao T; Nagahara A; Nakai Y; Nakayama M; Ichimaru N; Nonomura N; Okuyama A; Kimura M; Tomita Y; Yuien K
    Hinyokika Kiyo; 2008 Oct; 54(10):669-72. PubMed ID: 19048933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudosarcomatous myofibroblastic proliferation of the urinary bladder: a rare entity.
    Vasilakaki T; Koulia K; Tsavari A; Arkoumani E; Liaropoulos D; Manoloudaki K; Pavlis A; Stamatiou K
    Urology; 2014 Jun; 83(6):1409-11. PubMed ID: 24767825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1-ALK fusions.
    Acosta AM; Demicco EG; Dal Cin P; Hirsch MS; Fletcher CDM; Jo VY
    Mod Pathol; 2021 Feb; 34(2):469-477. PubMed ID: 32908253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudosarcomatous myofibroblastic proliferations of the bladder: a clinicopathologic study of 42 cases.
    Harik LR; Merino C; Coindre JM; Amin MB; Pedeutour F; Weiss SW
    Am J Surg Pathol; 2006 Jul; 30(7):787-94. PubMed ID: 16819319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of factors predicting intravesical recurrence of superficial transitional cell carcinoma of the bladder without concomitant carcinoma in situ.
    Sakai I; Miyake H; Harada K; Hara I; Inoue TA; Fujisawa M
    Int J Urol; 2006 Nov; 13(11):1389-92. PubMed ID: 17083389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for intravesical recurrence in patients with high-grade T1 bladder cancer in the second TUR era.
    Takaoka E; Matsui Y; Inoue T; Miyazaki J; Nakashima M; Kimura T; Oikawa T; Kawai K; Yoshimura K; Habuchi T; Ogawa O; Nishiyama H
    Jpn J Clin Oncol; 2013 Apr; 43(4):404-9. PubMed ID: 23444116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Carcinoma in situ of the bladder involving the prostate with an unusual invasive pattern following BCG therapy: a case report].
    Iba A; Kohjimoto Y; Inagaki T; Suzuki A; Fujii R; Senzaki H; Uekado Y; Shinka T
    Hinyokika Kiyo; 2005 Oct; 51(10):681-4. PubMed ID: 16285623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for positive findings in patients with high-grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette-Guérin therapy and the decision for a repeat TUR.
    Orsola A; Cecchini L; Raventós CX; Trilla E; Planas J; Landolfi S; de Torres I; Morote J
    BJU Int; 2010 Jan; 105(2):202-7. PubMed ID: 19558557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Case of Inflammatory Myofibroblastic Tumor of Urinary Bladder].
    Tanaka K; Ikeda A; Miyakawa T; Komine M; Tsutsumi M; Ishikawa S; Kawai K; Nishiyama H
    Hinyokika Kiyo; 2016 Apr; 62(4):201-4. PubMed ID: 27217015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Squamous carcinoma with pseudosarcomatous stroma of the renal pelvis and ureter: a case report].
    Kobayashi M; Hashimoto S; Hara Y; Kobayashi Y; Nakamura S; Tokue A; Shimizu H
    Hinyokika Kiyo; 1994 Jan; 40(1):55-9. PubMed ID: 8109476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guérin treatment.
    Kakiashvili DM; van Rhijn BW; Trottier G; Jewett MA; Fleshner NE; Finelli A; Azuero J; Bangma CH; Vajpeyi R; Alkhateeb S; Hanna S; Kostynsky A; Kuk C; Van Der Kwast TH; Zlotta AR
    BJU Int; 2011 Feb; 107(4):540-6. PubMed ID: 21276177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pseudosarcomatous lesions of the urinary bladder. Report of a case].
    Salvador Villalba I; Alemany Monraval P; Martínez Leandro E; Martorell Cebollada M
    Arch Esp Urol; 1997; 50(1):77-8. PubMed ID: 9182497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of intravesical instillation of pirarubicin for preventing recurrence of non-muscle invasive bladder cancer].
    Li Q; Xu T; Wang XF
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):904-7. PubMed ID: 20193328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment and follow-up of a case of recurrent pseudosarcomatous myofibroblastic proliferation.
    Lei JH; Yang L; Liu LR; Wei Q
    Saudi Med J; 2015 Mar; 36(3):363-5. PubMed ID: 25737182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of integrin proteins in non-muscle-invasive bladder cancer: significance of intravesical recurrence after transurethral resection.
    Behnsawy HM; Miyake H; Abdalla MA; Sayed MA; Ahmed Ael-F; Fujisawa M
    BJU Int; 2011 Jan; 107(2):240-6. PubMed ID: 20735384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrogenic adenoma of the bladder: two case reports and literature review.
    Nakatani T; Kuratsukuri K; Uchida J; Sugimura K; Kuroki Y; Morikawa Y
    Hinyokika Kiyo; 2002 Jul; 48(7):463-6. PubMed ID: 12229190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.